113 related articles for article (PubMed ID: 38147985)
1. [Evaluation of the humoral immunity in mice induced by foot-and-mouth disease virus-like particles-ZIF-8 complexes with different sizes].
Li J; Wang J; Zhang Y; Teng Z; Dong H; Guo H; Sun S
Sheng Wu Gong Cheng Xue Bao; 2023 Dec; 39(12):4837-4848. PubMed ID: 38147985
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticulate chitosan-TNF-α-VLPs activate mast cells and enhance adaptive immunity induced by foot-and-mouth disease virus-like particles in mice.
Bai R; Li M; Tian Z; Hu Y; An M; Yuan W; Li L
Vet Immunol Immunopathol; 2023 Oct; 264():110662. PubMed ID: 37862872
[TBL] [Abstract][Full Text] [Related]
3. FMD empty capsids combined with the Immunostant Particle Adjuvant -ISPA or ISA206 induce protective immunity against foot and mouth disease virus.
Bidart J; Mignaqui A; Kornuta C; Lupi G; Gammella M; Soria I; Galarza R; Ferella A; Cardillo S; Langellotti C; Quattrocchi V; Durocher Y; Wigdorovitz A; Marcipar I; Zamorano P
Virus Res; 2021 May; 297():198339. PubMed ID: 33596405
[TBL] [Abstract][Full Text] [Related]
4. Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate.
Lei Y; Shao J; Zhao F; Li Y; Lei C; Ma F; Chang H; Zhang Y
J Med Virol; 2019 Dec; 91(12):2142-2152. PubMed ID: 31347713
[TBL] [Abstract][Full Text] [Related]
5. Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge.
Bhat SA; Saravanan P; Hosamani M; Basagoudanavar SH; Sreenivasa BP; Tamilselvan RP; Venkataramanan R
Res Vet Sci; 2013 Dec; 95(3):1217-23. PubMed ID: 23969204
[TBL] [Abstract][Full Text] [Related]
6. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
[TBL] [Abstract][Full Text] [Related]
7. Hollow mesoporous silica nanoparticles as delivery vehicle of foot-and-mouth disease virus-like particles induce persistent immune responses in guinea pigs.
Bai M; Dong H; Su X; Jin Y; Sun S; Zhang Y; Yang Y; Guo H
J Med Virol; 2019 Jun; 91(6):941-948. PubMed ID: 30701562
[TBL] [Abstract][Full Text] [Related]
8. B cell memory responses induced by foot-and-mouth disease virus-like particles in BALB/c mice.
Liu JH; Zhang JJ; Han WJ; Cui C; Li MZ; Tian ZY; Bai RM; Li LM
Vet Immunol Immunopathol; 2022 Aug; 250():110458. PubMed ID: 35841772
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease.
Pan Q; Wang H; Ouyang W; Wang X; Bi Z; Xia X; Wang Y; He K
Vaccine; 2016 Jan; 34(4):578-585. PubMed ID: 26685093
[TBL] [Abstract][Full Text] [Related]
10. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y
Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796
[TBL] [Abstract][Full Text] [Related]
11. Enhanced protective immune response of foot-and-mouth disease vaccine through DNA-loaded virus-like particles.
Lu Y; Dong H; Li J; Li L; Wang M; Liu H; Teng Z; Zhang Y; Jin Y; Guo H; Yang Y; Wen X; Sun S
Microb Pathog; 2020 Jun; 143():104130. PubMed ID: 32165331
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective efficacy of a novel foot-and-mouth disease virus empty-capsid-like particle with improved acid stability.
Xie Y; Li H; Qi X; Ma Y; Yang B; Zhang S; Chang H; Yin X; Li Z
Vaccine; 2019 Mar; 37(14):2016-2025. PubMed ID: 30808570
[TBL] [Abstract][Full Text] [Related]
13. Expression of FMD virus-like particles in yeast
Zhang J; Ge J; Li J; Li J; Zhang Y; Shi Y; Sun J; Wang Q; Zhang X; Zhao X
J Vet Sci; 2023 Jan; 24(1):e15. PubMed ID: 36726280
[TBL] [Abstract][Full Text] [Related]
14. Golden-star nanoparticles as adjuvant effectively promotes immune response to foot-and-mouth disease virus-like particles vaccine.
Teng Z; Sun S; Chen H; Huang J; Du P; Dong H; Xu X; Mu S; Zhang Z; Guo H
Vaccine; 2018 Oct; 36(45):6752-6760. PubMed ID: 30268733
[TBL] [Abstract][Full Text] [Related]
15. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT
Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951
[TBL] [Abstract][Full Text] [Related]
16. Poly(I:C) and CpG improve the assembly of foot-and-mouth disease virus-like particles and immune response in mice.
Liu H; Teng Z; Dong H; Li J; Waheed Abdullah S; Zhang Y; Wu J; Guo H; Sun S
Virology; 2023 Feb; 579():94-100. PubMed ID: 36623353
[TBL] [Abstract][Full Text] [Related]
17. Potent neutralization activity against type O foot-and-mouth disease virus elicited by a conserved type O neutralizing epitope displayed on bovine parvovirus virus-like particles.
Chang J; Zhang Y; Yang D; Jiang Z; Wang F; Yu L
J Gen Virol; 2019 Feb; 100(2):187-198. PubMed ID: 30547855
[TBL] [Abstract][Full Text] [Related]
18. Mutation in the VP2 gene of P1-2A capsid protein increases the thermostability of virus-like particles of foot-and-mouth disease virus serotype O.
Ganji VK; Biswal JK; Lalzampuia H; Basagoudanavar SH; Saravanan P; Tamil Selvan RP; Umapathi V; Reddy GR; Sanyal A; Dechamma HJ
Appl Microbiol Biotechnol; 2018 Oct; 102(20):8883-8893. PubMed ID: 30136205
[TBL] [Abstract][Full Text] [Related]
19. Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency.
Mohana Subramanian B; Madhanmohan M; Sriraman R; Chandrasekhar Reddy RV; Yuvaraj S; Manikumar K; Rajalakshmi S; Nagendrakumar SB; Rana SK; Srinivasan VA
Antiviral Res; 2012 Dec; 96(3):288-95. PubMed ID: 23043941
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of virus like particle (VLP) vaccine of foot-and-mouth-disease virus (FMDV) type O adjuvanted with poly I:C or CpG in guinea pigs.
Terhuja M; Saravanan P; Tamilselvan RP
Biologicals; 2015 Nov; 43(6):437-43. PubMed ID: 26493006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
